Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$17.63 - $21.74 $1.21 Million - $1.49 Million
-68,722 Reduced 30.14%
159,323 $3.14 Million
Q4 2023

Feb 14, 2024

SELL
$14.37 - $19.07 $1.37 Million - $1.82 Million
-95,533 Reduced 29.52%
228,045 $4 Million
Q3 2023

Nov 14, 2023

SELL
$13.62 - $20.2 $2.55 Million - $3.79 Million
-187,444 Reduced 36.68%
323,578 $5.62 Million
Q2 2023

Aug 14, 2023

BUY
$10.44 - $16.48 $1.08 Million - $1.7 Million
103,260 Added 25.32%
511,022 $7.2 Million
Q1 2023

May 15, 2023

BUY
$10.7 - $15.79 $2.81 Million - $4.15 Million
262,747 Added 181.19%
407,762 $4.39 Million
Q4 2022

Feb 14, 2023

BUY
$11.42 - $17.05 $1.66 Million - $2.47 Million
145,015 New
145,015 $2.17 Million
Q1 2021

May 17, 2021

SELL
$16.68 - $23.97 $256,705 - $368,898
-15,390 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$14.8 - $21.15 $42,446 - $60,658
-2,868 Reduced 15.71%
15,390 $272,000
Q3 2020

Nov 16, 2020

BUY
$15.21 - $25.53 $106,728 - $179,144
7,017 Added 62.42%
18,258 $280,000
Q2 2020

Aug 17, 2020

BUY
$15.08 - $26.0 $169,514 - $292,266
11,241 New
11,241 $286,000

Others Institutions Holding KNSA

About Kiniksa Pharmaceuticals, Ltd.


  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $751M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.